Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Triple Negative Breast Cancer|Dietary Exposure|Fasting
Interventions: DIETARY_SUPPLEMENT: Control diet (ARM A) or Fasting-Like Approach (FLA, ARM B)
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Collaborators: Istituto Oncologico Veneto IRCCS|Ospedale Policlinico San Martino|Federico II University|Azienda Policlinico Umberto I|European Institute of Oncology|Ospedale "Carlo Poma" - Mantova|Humanitas Clinical and Research Center